CN101684140A - Preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide - Google Patents

Preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide Download PDF

Info

Publication number
CN101684140A
CN101684140A CN200810151758A CN200810151758A CN101684140A CN 101684140 A CN101684140 A CN 101684140A CN 200810151758 A CN200810151758 A CN 200810151758A CN 200810151758 A CN200810151758 A CN 200810151758A CN 101684140 A CN101684140 A CN 101684140A
Authority
CN
China
Prior art keywords
virus
avian influenza
vaccine
disease virus
influenza virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810151758A
Other languages
Chinese (zh)
Inventor
田杏芳
王连民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Shengji Group Co Ltd
Original Assignee
Tianjin Shengji Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Shengji Group Co Ltd filed Critical Tianjin Shengji Group Co Ltd
Priority to CN200810151758A priority Critical patent/CN101684140A/en
Publication of CN101684140A publication Critical patent/CN101684140A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide, which includes the steps of: (1) using avian influenza viral vaccine, newcastle disease virus vaccine, chicken bursa viral vaccine immune experiment pig; (2) closely monitoring vaccine immune antibody level of experiment pig in vivo,when the antibody reaches a peak value, sterilizedly fetching splenic organ or anticoagulated blood of experiment pig for preparing lymphocyte mono-layer; (3) executing subculture for lymphocyte mono-layer; (4) inducing and culturing the lymph subculture cell after which grows into a mono-layer with phaescolosaxin, then the anti-avian influenza virus, newcastle disease virus chicken bursa virus specific transfer and antimicrobial peptide are obtained. The product prepared by the method does not need to be purified further, and can be treated by ultrasonic and freeze thawing simple process intoa mixer for directly being used for bird in vivo, thereby playing roles for resisting avian influenza virus, newcastle disease virus, chicken bursa virus and bacteria, simultaneously improving immunity of bird.

Description

The preparation method of anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide
Technical field
The present invention relates to the preparation method of a kind of antiviral specific transfer factor and antibacterial peptide, particularly relate to the production method of a kind of anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide.
Background technology
Transfer factor is a kind of lymphokine that extracts from the intact animal white corpuscle of exotic antigen sensitization, or a kind of lymphokine that extracts the animal hemocyte from the decubation after certain antigenic stimulation.The former claims non-specific transfer factor, and the latter then claims specific transfer factor.But these two kinds of transfer factor the most important thing is the transfer cell immunologic function in vivo and in vitro, as a kind of immunological reagent of adoptive immunotherapy, and the multiple vital role of performance in immunity system.
The present preparation method of transfer factor is: fresh or refrigerated spleen and lymphoglandula are removed fat and reticular tissue about 25 ℃ with animal, clean with purified water then; The tissue of cleaning is cut into small pieces, adds suitable quantity of water, use tissue mashing machine's smudge cells, make homogenate, add an amount of purified water, mixing is put-20 ℃ of multigelations 5~8 times, and melt temperature must not be above 37 ℃; With the homogenate of freeze thawing centrifugal (4 ℃ of centrifuging temperatures), go precipitation, stay supernatant liquor standby; Supernatant liquor dress dialysis tubing was dialysed the work in-process filtration sterilization 24-48 hour; The configuration of finished product and check.
Antibacterial peptide is through inducing, by the defensive peptide class active substance that resists exogenous pathogenic agent that the animal immune system of defense produces, molecular weight is little, activity is strong, has antibacterium, fungi, virus and protozoon effect, even cancer cells also had lethal effect, use very extensive.Present preparation method is to be raw material with new freshly-slaughtered poultry small intestine, degrease, serous coat and content, and freezing the shredding in back of weighing smashed pulping to pieces.Water proof boiled 15 minutes after the homogenate, added 5% acetate according to 1: 1 ratio, and stirred under 4 ℃ of conditions and spend the night, next day with mixture under 4 ℃ of temperature condition with 8000 rev/mins centrifugal 30 minutes, get supernatant, be kept in 4 ℃ of environment.Throw out is mixed with equal-volume 5% acetate, place 4 ℃ of stirring and leaching to spend the night again, repeat above-mentioned centrifugal process, get supernatant, merge supernatant liquor twice, adjust the pH value, recentrifuge is abandoned precipitation, and supernatant liquor lyophilize product are antibacterial peptide.
The main drawback of prior art for preparing transfer factor and antibacterial peptide is not have specificity at disease, the result of treatment instability.
Summary of the invention
The objective of the invention is to overcome the antibacterial peptide and the transfer factor that prepare in the prior art and do not have specificity at disease, shortcomings such as result of treatment instability provide that a kind of production technique is simple, cost is low, output capacity is high, the preparation method of the anti-avian influenza virus of better effects if, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide.
Technical solution of the present invention is summarized as follows:
The preparation method of a kind of anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide, be made up of following steps:
(1) with each 1-5mL intramuscular injection immunity 40-120 age in days experiment pig of avian influenza virus vaccine, Avian pneumo-encephalitis virus vaccine, bursal disease virus of chickens vaccine, after the first immunisation 7-20 days, again with each 2mL intramuscular injection booster immunization of above-mentioned vaccine;
(2) close monitoring experiment pig body intradermal vaccine immune antibody level, when the antibody horizontal value of peaking, aseptic experiment pig spleen or the anticoagulation taked prepares the lymphocyte individual layer with spleen or anticoagulation;
(3) to the cultivation of going down to posterity of lymphocyte individual layer;
(4) after the lymph passage cell grows up to individual layer, use the phytohaemagglutinin inducing culture, promptly obtain anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide.
Advantage of the present invention:
The present invention uses avian influenza virus earlier, Avian pneumo-encephalitis virus, the bursal disease virus of chickens immune animal, be raw material with pig spleen after the less immunity or anticoagulation cirumferential blood again, make the lymphocyte individual layer, in vitro culture, the induction of lymphocyte individual layer is produced a large amount of anti-avian influenza virus, Avian pneumo-encephalitis virus, the mixture of specificity of bursal disease virus of chickens transfer factor and antibacterial peptide, the anti-avian influenza virus of method preparation of the present invention, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide need not further purification, can directly mixture be used in the bird body after involving the freeze thawing simple process through ultrasonic, can play anti-avian influenza virus, Avian pneumo-encephalitis virus, bursal disease virus of chickens and antimicrobial effect improve the immunizing power of bird simultaneously.
Embodiment
The present invention is further illustrated below in conjunction with specific embodiment.
Embodiment 1
The preparation method of a kind of anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide, step:
(1). immunity:
With each 1mL intramuscular injection immunity 90 age in days experiment pig of avian influenza virus vaccine, Avian pneumo-encephalitis virus vaccine, bursal disease virus of chickens vaccine, set up the blank group synchronously, first immunisation the 15th day, again with each the 2mL intramuscular injection of above-mentioned vaccine as booster immunization;
(2) close monitoring experiment pig body intradermal vaccine immune antibody level, when the antibody horizontal value of peaking, the aseptic experiment pig spleen of taking prepares the lymphocyte individual layer with spleen, and step is:
A, processing pig spleen
Get the fresh pig spleen and place aseptic Glass Containers, add PBS (pH is 7.2) solution soaking half an hour (or be dipped in mass percentage concentration be in 1% the bromogeramine solution), taking-up is with alcohol disinfecting spleen surface, remove spleen fat and coating with Dissecting scissors and tweezers, wash once with PBS (pH is 7.2) liquid, spleen being cut into segment moves in the plate again, with eye scissors spleen is cut into the 1mm3 fritter at last, use PBS (pH is 7.2) liquid washing again 3 times, to remove hemocyte, coloring matter and to shred the cell of physical abuse in the process;
B, digestion and dispersion tissue's piece
PBS (pH7.2) liquid that the last step was cleaned sops up, the tissue block that shreds is moved in the Erlenmeyer flask, adds 0.25% trypsin solutions (pH is 7.7) by 5 times of amounts of tissue block volume, puts in 37 ℃ of water-baths to digest 30 minutes.Shook one time Erlenmeyer flask every 10 minutes, so that tissue block is scattered, in order to continuing digestion, up to tissue become loose, surperficial when scared till, at this moment from water-bath, take out Erlenmeyer flask, inhale and remove trypsin solution, use PBS (pH is 7.2) liquid washing 3 times again, use 0.5% lactoalbumin hydrolysate---Hanks liquid is washed, and with the big slightly tubule piping and druming several of bore, filters with four layers of gauze;
C, cell counting
Employing indicates the blood counting chamber of 0.1mm printed words and counts, and method of counting is identical with white blood cell count(WBC);
The packing of D, cell suspension and cultivation
By the cell counting result, cell suspension is adjusted to 600,000/ml cells suspension with moral DMEM nutritive medium.With cell suspension branch pack into Tissue Culture Flask and cell rolling bottle, dividing loading amount is 1/5 of this bottle capacity, closes the lid, and carries out sign, Tissue Culture Flask and rolling bottle is placed on respectively on CO2gas incubator and the Rotary Machine cultivates then;
E, observation
Place 37 ℃ of cultured cells, need observe day by day.If cell is grown, then want the morphological specificity of observation of cell and judge its residing growth phase (free phase, adsorption cycle, nursery stage, the phase of keeping and paracme), until forming the lymphocyte individual layer.
(3) to the cultivation of going down to posterity of lymphocyte individual layer
Before doing the passage cell cultivation, at first place microscopically now to examine on culturing bottle, to determine that cell has grown up to individual layer, can carry out the cultivation of going down to posterity of cell.
(4) after the lymph passage cell grows up to individual layer, use the phytohaemagglutinin inducing culture.
After spleen lymph passage cell grew up to individual layer, replacing was kept liquid and is added the phytohaemagglutinin inducing culture simultaneously.
Inducing culture was tested to product after 24 hours:
Cell culture taken a sample after ultrasonication detect the concentration of transfer factor and antibacterial peptide.The mensuration of transfer factor concentration: quantitatively many quantitative to transfer factor:, be a transfer factor unit with content of peptides 1mg with Folin-phenol method or spectrophotometry content of peptides with content of peptides.The transfer factor content of this explained hereafter be conventional produce 4~5 times.
The antibacterial peptide concentration determination: adopting the Xylene Brilliant Cyanine G method to measure, is standardized solution with the bovine serum albumin, and Coomassie brilliant blue G250 is a developer, the concentration of the antibacterial peptide of producing at spectrophotometric determination.The concentration of the antibacterial peptide that present method is produced is 10 times of conventional extracted amount.
Application example
150 15 age in days fryer (aseptic through physical examination) are divided into totally 5 groups of A, B, C, D, E, and 30 every group, B, C, D, E group are attacked the poison back through the strong poison of artificial challenge's 0.1ml hybrid virus newcastle disease virus and tested.A group is healthy group, infective virus not, not administration; B organizes negative control group, infective virus, not administration; C group and D group are the product of method preparation of the present invention, and the C group is low dose group, press 0.02g/ chicken/sky injection; The D group is the pharmaceutical composition high dose group, presses 0.04g/ chicken/sky injection; The E group is pressed 0.1g/ chicken/sky administration for tradition " astragalus polysaccharides " treatment group.The result shows, adopts the product of preparation method's preparation of a kind of antiviral specific transfer factor of the present invention and antibacterial peptide that chicken bursal disease is had the obvious treatment effect.
Experimental result is as follows:
Numbering Group Mortality ratio % Curative ratio % Efficient %
??A Healthy group ??0 ??20.6(8/30) ??100.0(40/30)
??B Negative control group ??96.7(29/30) ??3.3(1/30) ??3.3(1/30)
??C The low dose therapy group ??20.0(6/30) ??50.0(15/30) ??80.0(24/30)
??D The high-dose therapy group ??10.3(4/30) ??83.3(25/30) ??86.6(26/30)
??E " astragalus polysaccharides " treatment group ??26.7(8/30) ??60.0(18/30) ??73.3(22/30)
The result shows, (P<0.01=illustrates that the product of preparation method's preparation of a kind of anti-chicken virus specific transfer factor of the present invention and antibacterial peptide has significant therapeutic action to Newcastle disease for low dose therapy group, high-dose therapy group and negative control group difference highly significant; Particularly the high-dose therapy group is used and obviously is better than tradition " astragalus polysaccharides " treatment group curative effect (P<0.01).
The antibacterial peptide bacteriostatic experiment:
Bacteriostatic experiment shows that the antibacterial peptide micromolar concentration that the present invention produced can be killed gram-positive, gram-negative bacteria and the fungi more than 73%.Its has a broad antifungal spectrum, can suppress the nearly 150 strain strain isolateds of kind surplus staphylococcus, Hemolytic streptococcus, intestinal bacteria, aerogenesis Zymomonas mobilis, Pseudomonas aeruginosa, pasteurellosis bacillus, Salmonellas, actinomycetes, the mycobacterium etc. ten, and in the experiment antibacterial circle diameter on the bacterium more than the 22mm more than 71%.
The check of work in-process and finished product:
The work in-process calibrating: work in-process carry out a detection such as bacterial endotoxin, sterility test, pH value.
Finished product calibrating: finished product is made the telling test, outward appearance detections, pH value, content of peptides, SAE, proteins react, sterility test, bacterial endotoxin, undue toxicity of transfer factor and antibacterial peptide etc. respectively and is checked.
Embodiment 2
The preparation method of a kind of anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide, step:
(1) immunity:
With each 1.2mL intramuscular injection immunity 50 age in days experiment pig of avian influenza virus, Avian pneumo-encephalitis virus, bursal disease virus of chickens vaccine, set up the blank group synchronously, after the first immunisation the 7th day, again with each the 2.5mL intramuscular injection of above-mentioned vaccine as second immunisation; After secondary is exempted from time the 10th day, again with above-mentioned vaccine 3mL intramuscular injection as three immunity;
(2) close monitoring experiment pig body intradermal vaccine immune antibody level, when the antibody horizontal value of peaking, the aseptic anticoagulation of taking prepares the lymphocyte individual layer with anticoagulation cirumferential blood, and step is:
Aseptic vein is taked 250 milliliters of animal's whole bloods, add 1.2% heparin solution 15mL anti-freezing, left standstill 90 minutes, with all blood plasma more than the band glueballs suction pipe absorption red corpuscle layer, the leukocytic cream that particularly is right after on the red corpuscle layer will be drawn as far as possible, be sub-packed in the sterilization centrifuge tube, with PBS (pH is 7.2) liquid repetitive scrubbing 2 times, 1000 rev/mins of centrifugal speeds, carry out white corpuscle and cultivate with containing 40 milliliters of 30% calf serum lactoalbumin hydrolysates then, being sub-packed in 100 milliliters of capacity behind the uniform mixing cultivates in square vase or the brick bottle, the jam-pack bottle stopper was put in 37 ℃ of thermostat containers or in the brick bottle machine and is cultivated, through 3 days, white corpuscle is evenly adherent, promptly makes the lymphocyte individual layer.
(3) to the cultivation of going down to posterity of lymphocyte individual layer;
Before doing the passage cell cultivation, at first culturing bottle is placed microscopically to observe, to determine that cell has grown up to individual layer, can carry out the cultivation of going down to posterity of cell.
(4) after the lymph passage cell grows up to individual layer, use the phytohaemagglutinin inducing culture.
After the hemolymph passage cell grew up to individual layer, replacing was kept liquid and is added the phytohaemagglutinin inducing culture simultaneously.
The Interventions Requested of the method for the mensuration of transfer factor concentration, antibacterial peptide bacteriostatic experiment, work in-process and finished product are all with embodiment 1.
Embodiment 3
The preparation method of a kind of anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide
(1) with each 5mL intramuscular injection immunity 40 age in days experiment pig of avian influenza virus vaccine, Avian pneumo-encephalitis virus vaccine, bursal disease virus of chickens vaccine, after the first immunisation the 10th day, again with each 2mL intramuscular injection booster immunization of above-mentioned vaccine;
(2) close monitoring experiment pig body intradermal vaccine immune antibody level, when the antibody horizontal value of peaking, aseptic experiment pig spleen or the anticoagulation taked prepares the lymphocyte individual layer with spleen or anticoagulation;
(3) to the cultivation of going down to posterity of lymphocyte individual layer;
(4) after the lymph passage cell grows up to individual layer, use the phytohaemagglutinin inducing culture, promptly obtain anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide.
Embodiment 4
The preparation method of a kind of anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide
(1) with each 1.5mL intramuscular injection immunity 120 age in days experiment pig of avian influenza virus vaccine, Avian pneumo-encephalitis virus vaccine, bursal disease virus of chickens vaccine, after the first immunisation the 20th day, again with each 2mL intramuscular injection booster immunization of above-mentioned vaccine;
(2) close monitoring experiment pig body intradermal vaccine immune antibody level, when the antibody horizontal value of peaking, aseptic experiment pig spleen or the anticoagulation taked prepares the lymphocyte individual layer with spleen or anticoagulation;
(3) to the cultivation of going down to posterity of lymphocyte individual layer;
(4) after the lymph passage cell grows up to individual layer, use the phytohaemagglutinin inducing culture, promptly obtain anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide.

Claims (1)

1. the preparation method of an anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide is characterized in that being made up of following steps:
(1) with each 1-5mL intramuscular injection immunity 40-120 age in days experiment pig of avian influenza virus vaccine, Avian pneumo-encephalitis virus vaccine, bursal disease virus of chickens vaccine, after the first immunisation 7-20 days, again with each 2mL intramuscular injection booster immunization of above-mentioned vaccine;
(2) close monitoring experiment pig body intradermal vaccine immune antibody level, when the antibody horizontal value of peaking, aseptic experiment pig spleen or the anticoagulation taked prepares the lymphocyte individual layer with spleen or anticoagulation;
(3) to the cultivation of going down to posterity of lymphocyte individual layer;
(4) after the lymph passage cell grows up to individual layer, use the phytohaemagglutinin inducing culture, promptly obtain anti-avian influenza virus, Avian pneumo-encephalitis virus, specificity of bursal disease virus of chickens transfer factor and antibacterial peptide.
CN200810151758A 2008-09-25 2008-09-25 Preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide Pending CN101684140A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810151758A CN101684140A (en) 2008-09-25 2008-09-25 Preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810151758A CN101684140A (en) 2008-09-25 2008-09-25 Preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide

Publications (1)

Publication Number Publication Date
CN101684140A true CN101684140A (en) 2010-03-31

Family

ID=42047544

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810151758A Pending CN101684140A (en) 2008-09-25 2008-09-25 Preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide

Country Status (1)

Country Link
CN (1) CN101684140A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102453088A (en) * 2010-10-22 2012-05-16 曹吉祥 Anti-chicken infectious bursal disease specific transfer factor and preparation method thereof
CN102861333A (en) * 2012-10-17 2013-01-09 济南大东农生物技术有限公司 High-activity composite antibody oral preparation for resisting bursa fabricius viruses and influenza viruses of chicken
CN102864154A (en) * 2010-12-22 2013-01-09 山东省农业科学院家禽研究所 A group of Cathelicidins antimicrobial peptides of chicken, preparation method and application thereof
CN103393721A (en) * 2013-08-19 2013-11-20 苟鸿鹰 Preparation technology and medical applications of compound specific transfer factor
CN104208682A (en) * 2013-09-30 2014-12-17 郑州后羿制药有限公司 Composition for preventing chicken Newcastle disease and chicken bursal disease, mixed freeze-dried powder and preparation method
CN109260468A (en) * 2018-09-30 2019-01-25 派生特(福州)生物科技有限公司 A kind of preparation method and application of Swine spleen transfer factor and chicken bursa element mixed liquor

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102453088A (en) * 2010-10-22 2012-05-16 曹吉祥 Anti-chicken infectious bursal disease specific transfer factor and preparation method thereof
CN102864154A (en) * 2010-12-22 2013-01-09 山东省农业科学院家禽研究所 A group of Cathelicidins antimicrobial peptides of chicken, preparation method and application thereof
CN102861333A (en) * 2012-10-17 2013-01-09 济南大东农生物技术有限公司 High-activity composite antibody oral preparation for resisting bursa fabricius viruses and influenza viruses of chicken
CN102861333B (en) * 2012-10-17 2013-09-25 济南大东农生物技术有限公司 High-activity composite antibody oral preparation for resisting bursa fabricius viruses and influenza viruses of chicken
CN103393721A (en) * 2013-08-19 2013-11-20 苟鸿鹰 Preparation technology and medical applications of compound specific transfer factor
CN103393721B (en) * 2013-08-19 2016-01-27 苟鸿鹰 Compound specific transfer factor preparation technology and medical usage
CN104208682A (en) * 2013-09-30 2014-12-17 郑州后羿制药有限公司 Composition for preventing chicken Newcastle disease and chicken bursal disease, mixed freeze-dried powder and preparation method
CN104208682B (en) * 2013-09-30 2016-08-17 郑州后羿制药有限公司 A kind of anti-newcastle disease, the compositions of avian infectious bursal disease, freeze-dried mixed powder and preparation method
CN109260468A (en) * 2018-09-30 2019-01-25 派生特(福州)生物科技有限公司 A kind of preparation method and application of Swine spleen transfer factor and chicken bursa element mixed liquor

Similar Documents

Publication Publication Date Title
Thongthai et al. Studies on the virulence of Neisseria gonorrhoeae I. relation of colonial morphology and resistance to phagocytosis by polymorphonuclear leukocytes
CN103479995B (en) Preparation method of mycoplasma gallisepticum and mycoplasma synoviae bivalent inactivated vaccine
CN103495166B (en) Preparation method of complex live vaccine for porcine reproductive and respiratory syndrome
CN101684140A (en) Preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide
CN104258385B (en) BHK-21 cell entirely suspend culture technique newcastle disease vaccine produce in application
CN102936612B (en) Method for preparing anti-canine distemper virus monoclonal antibody by adopting bioreactor
CN101612396B (en) Canine distemper live vaccine and preparation method thereof
CN112779193B (en) Virulent strain of mycoplasma synoviae and application thereof
CN106591231B (en) BCG polysaccharide nucleic acid for promoting proliferation and differentiation of CIK cells, culture medium, culture method and application
CN111000993A (en) Bivalent inactivated vaccine for duck viral hepatitis and duck reovirus disease and preparation method thereof
CN101099864A (en) Method for preparing inactivated vaccine both for preventing chicken Newcastle disease and infectious bronchitis
CN101757027A (en) Method for extracorporeally preparing transfer factor against specificity of infectious bronchitis virus of chickens
CN103172732A (en) Anti-gosling plague egg yolk antibody and preparation method thereof
CN101099863B (en) Method for preparing triple inactivated vaccine for preventing chicken Newcastle disease, infectious bronchitis and egg drop syndrome
CN101759765A (en) Method for extracorporeally preparing transfer factor against specificity of bursal disease virus of chickens
CN103386127B (en) Method for preparing vaccine by Newcastle disease virus cultured by using chick embryo continuous cell line and bioreactor
CN101684141A (en) Preparation method of specific transfer factor for resisting chicken bursa virus and antimicrobial peptide
CN101684142A (en) Preparation method of anti-avian influenza virus specific transfer factor and antimicrobial peptide
CN103599130A (en) Preparation method of anti-neweastle disease virus specific transfer factor and oral liquid, and use thereof
CN101684143A (en) Preparation method of anti-new castle disease virus specific transfer factor and antimicrobial peptide
CN100564519C (en) The vitro culture induction of lymphocyte prepares the method for antibacterial peptide and transfer factor
CN104873971A (en) Diluent for hog cholera live vaccine (spleen and lymph tissue origin)
CN104873978A (en) Freeze-drying protective agent for hog cholera live vaccine (spleen and lymph tissue origin)
CN101759764A (en) Method for extracorporeally preparing transfer factor against specificity of Newcastle disease virus of chickens
CN102151290B (en) Preparation method of poultry specific transfer factors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100331